PFIZER INC Effective Income Tax Rate Reconciliation, Tax Credit, Percent
PFIZER INC (PFE) reported Effective Income Tax Rate Reconciliation, Tax Credit, Percent of 1.80% for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-27.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits · last filed 2025-02-27
- PFIZER INC effective income tax rate reconciliation, tax credit, percent for fiscal 2024 was 1.80%, a 88.61% decline from fiscal 2023.
- PFIZER INC effective income tax rate reconciliation, tax credit, percent for fiscal 2023 was 15.80%, a 2533.33% increase from fiscal 2022.
- PFIZER INC effective income tax rate reconciliation, tax credit, percent for fiscal 2022 was 0.60%, a 20.00% increase from fiscal 2021.
- PFIZER INC effective income tax rate reconciliation, tax credit, percent for fiscal 2021 was 0.50%, a 64.29% decline from fiscal 2020.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Percent 12 month | Effective Income Tax Rate Reconciliation, Tax Credit, Percent 12 month as first filed |
|---|---|---|
| 2024-12-31 | 1.80% 10-K · filed 2025-02-27 | |
| 2023-12-31 | 15.80% 10-K · filed 2025-02-27 | |
| 2022-12-31 | 0.60% 10-K · filed 2025-02-27 | |
| 2021-12-31 | 0.50% 10-K · filed 2024-02-22 | |
| 2020-12-31 | 1.40% 10-K · filed 2023-02-23 | 1.30% 10-K · filed 2021-02-25 |
| 2019-12-31 | 0.80% 10-K · filed 2022-02-24 | 0.50% 10-K · filed 2020-02-27 |
| 2018-12-31 | 2.20% 10-K · filed 2021-02-25 | 0.70% 10-K · filed 2019-02-28 |
| 2017-12-31 | 0.70% 10-K · filed 2020-02-27 | |
| 2016-12-31 | 1.00% 10-K · filed 2019-02-28 | |
| 2015-12-31 | 1.00% 10-K · filed 2018-02-22 | |
| 2014-12-31 | 0.90% 10-K · filed 2017-02-23 | -0.90% 10-K · filed 2015-02-27 |
| 2013-12-31 | 0.80% 10-K · filed 2016-02-29 | -0.80% 10-K · filed 2014-02-28 |
| 2012-12-31 | -0.30% 10-K · filed 2015-02-27 | |
| 2011-12-31 | -0.90% 10-K · filed 2014-02-28 | |
| 2010-12-31 | -2.30% 10-K · filed 2013-02-28 | |
| 2009-12-31 | -1.30% 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |